A Study to Evaluate the Effects of Natalizumab Treatment on Surface Integrin Expression on Monocyte in Patients With Multiple Sclerosis (MS)
Latest Information Update: 25 Feb 2016
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
Most Recent Events
- 25 Feb 2016 New trial record